When implementing interventions at the systems-level of practice, the public health nurse would:
a. Involve the entire community in solving the health problem.
b. Identify health problems in the community.
c. Change laws, policies, and practices that influence population-based issues.
d. Provide outreach services to populations at risk.
C
Systems-level practice consists of changing laws, policies, and practices that influence popula-tion-based issues.
You might also like to view...
Identify the best course of action by the researcher who finds no statistical significance during the analysis of data
1. The researcher should table the study due to a lack of viability. 2. The researcher should reevaluate the study for revision prior to publication. 3. The researcher must be certain the study identifies a need for change in order to be of value to the nursing community. 4. The researcher should report the findings as not significant for recommending change in practice or education.
The patient is receiving dapsone (DDS) for treatment of leprosy. While the patient is receiving dapsone, the primary care provider should plan to monitor the patient's:
a. Complete blood count b. Potassium level c. Urine output d. Calcium level
Classes on breast self-exam are an example of which of the following levels of prevention with regard to population-focused CNS activities?
1. Primary prevention 2. Secondary prevention 3. Tertiary prevention 4. Assessment
C.O. is a 43-year-old woman who noted a nonpruritic nodular rash on her neck and chest approximately
6 weeks ago. The rash became generalized, spreading to her head, abdomen, and arms and was accompanied by polyarticular joint pain and back pain. About 2 weeks ago, she experienced three episodes of epistaxis in 1 day. Over the past week, her gums became swollen and tender and she was severely fatigued. Because of the progression of symptoms, she sought medical attention. Lab work was performed, and C.O. was directly admitted to the hematology/ oncology unit under the care of a hematologist for diagnostic evaluation. Her chest x-ray examination showed normal lung expansion and heart size, without lymphadenopathy. Skin biopsy showed cutaneous leukemic infiltrates, and bone marrow biopsy showed moderately hypercellular marrow and collections of monoblasts. Her lumbar puncture specimen was free of blast cells. The final diagnosis was acute myeloblastic leukemia. C.O. is to begin remission induction therapy with cytarabine (Ara-C) 100mg/m2/day as a continuous infusion for 7 days and idarubicin (Idamycin) 12mg/m2/day intravenous (IV) push for 3 days. She is scheduled in angiography for placement of a triple-lumen subclavian Hickman catheter before beginning her therapy. Interpret C.O.'s CBC results. What does the presence of blasts in the differential mean?